US says it's 'working nonstop' to deliver supplies India needs for Covid-19

'We have always stood in solidarity with our friends and our partners in India,' says State Department.

Joe Biden
Joe Biden proposed a 21% global minimum tax as part of his corporate tax overhaul
Press Trust of India Washington
4 min read Last Updated : Apr 27 2021 | 6:11 AM IST
The Biden administration is working nonstop to do all it can to deliver on an urgent basis the supplies most needed by India to combat the deadly COVID-19 wave, the US State Department said here.

The current situation in India is of great concern to the United States, State Department spokesperson Ned Price told reporters at his daily news conference on Monday.

"We have always stood in solidarity with our friends and our partners in India," he added.

"We are working nonstop across the government to do all we can to deliver on an urgent basis the supplies most needed within India, and that includes oxygen assistance and related materials, but it also includes supplies for therapeutics, rapid diagnostic test kits, ventilators, personal protective equipment, or PPE, all supplies to protect India's frontline healthcare workers," Price said.

The assistance includes raw materials urgently required for the manufacture of the Covishield vaccine, he said.

The US is also deploying an expert team of public health advisers from the CDC to work in close collaboration with the US embassy on the ground, India's health ministries and its epidemic intelligence staff.

On Monday, US President Joe Biden spoke with Prime Minister Narendra Modi.

"The Secretary (of State) Tony Blinken has had an opportunity in recent days to speak to his counterpart, Foreign Minister Jaishankar. Jake Sullivan, the national security adviser, spoke to his counterpart," Price said.

Wendy Sherman, Deputy Secretary of State, spoke to her counterpart as well, he added.

"We have been doing that to demonstrate our solidarity with the Indian government, with the Indian people, but also to hear about the needs of the Indian government and to assess, based on our own capacity, what more we could do," Price said.

Responding to a question, Price said India is a priority given that the country is experiencing a horrific outbreak of the COVID-19 pandemic.

"We have a global comprehensive strategic partnership with India. But the secretary has been clear this is not about shots in arms in return for political favours, in return for any sort of transactionalism. This is about America's humanitarian leadership, the commitment that this administration has to help those most in need," Price said.

"Of course, what India is enduring now is profoundly concerning on so many levels. And so, that's why you see not only the United States stepping up, but other countries in the region well beyond stepping up to attempt to help and do all we can to help India in its time of need," he said.

From the earliest days of this pandemic, the United States has provided much needed assistance to India, just as India came to our aid to when the US was in the worst phase of the outbreak, he said.

"Since the beginning of the pandemic, the United States has provided nearly USD19 million in total assistance, and that includes nearly USD11 million and health assistance to help India so the spread of COVID-19," Price said.

The American assistance has helped India provide care for the affected, disseminate essential public health messages to various communities, strengthen the epidemiological surveillance capabilities, mobilise innovative financing mechanisms for emergency preparedness and response to the pandemic, he said.

The CDC has also committed USD3.6 million to assist the government of India's response to the epidemic.

"We recognise that, as the current outbreak has taken incredibly concerning turns in India, that there was more we could do. And we, in consultation with our Indian partners, have determined that the steps I referred to earlier are available to us, and they would be of great benefit to our partners in India," Price added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineJill BidenSerum Institute

First Published: Apr 27 2021 | 6:00 AM IST

Next Story